Page last updated: 2024-10-30

ly 171883 and Hyperplasia

ly 171883 has been researched along with Hyperplasia in 1 studies

LY 171883: structure in first source; leukotriene receptor antagonist
tomelukast : A member of the class of acetophenones that is 1-phenylethanone substituted at position 2 by a hydroxy group, a propyl group at position 3 and a 4-(1H-tetrazol-5-yl)butoxy group at position 4. A leukotriene antagonist, it exhibits anti-asthmatic activity.

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research Excerpts

ExcerptRelevanceReference
"Survival was not adversely affected by treatment, however, body weight of males and females in the high dose group was significantly lower than that of controls."1.28Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 mice. ( Bendele, AM; Eacho, PI; Foxworthy, PS; Hoover, DM; van Lier, RB, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bendele, AM1
Hoover, DM1
van Lier, RB1
Foxworthy, PS1
Eacho, PI1

Other Studies

1 other study available for ly 171883 and Hyperplasia

ArticleYear
Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 mice.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1990, Volume: 15, Issue:4

    Topics: Acetophenones; Animals; Autacoids; Body Weight; Carcinogens; Chemical and Drug Induced Liver Injury;

1990